Table 2.
Tumor type | Country | Treatment date | Carrier type | Ref. |
---|---|---|---|---|
GBM | Finland | 2008 | BPA | 115 |
Head and neck | Finland | 2011 | BPA | 116 |
Glioblastoma | Japan | 2009 | BPA and BSH | [117], [118] |
Head and neck | Japan | 2014 | BPA | 119 |
Malignant glioma | Japan | 2009 | BPA | [120], [121] |
Malignant meningioma | Japan | 2012 | BPA | 122 |
Head and neck | Taiwan | 2010–2011 | BPA | 123 |
Hepatic | Japan | 2014 | BSH | 124 |
Lung | Japan | 2012 | – | 125 |
Extra-mammary Paget's disease | Japan | 2012 | – | 126 |
GBM | USA | 1994–1999 | BPA | [86], [98], [127], [128] |
GBM | Sweden | 2001–2003 | BPA | [106], [129], [130], [131] |
GBM | Germany | 2004–2006 | BPA | 132 |
GBM | Czech Republic | 2000–2002 | BSH | 133 |